Synthis Therapeutics, Inc.
Synthis Therapeutics, Inc. is a small business in New York, NY registered on SAM.gov to bid on federal contracts. It has won 4 small business R&D awards worth $3.1 million through the SBIR and STTR programs since 2018, according to SBIR.gov.
- UEI
- KC6RHFHRQAN6
- CAGE code
- 7NWT8
- SAM.gov registration
- Active
Registration details
From SAM.gov's monthly public file dated Oct 5, 2026. If the business has updated its registration since, SAM.gov shows the newer details.
| Legal business name | Synthis Therapeutics, Inc. |
|---|---|
| Unique Entity ID (UEI) | KC6RHFHRQAN6 |
| CAGE code | 7NWT8 |
| Location | New York, NY |
| SAM.gov registration | Active through Jan 27, 2027 |
| Business started | 2016 |
| Primary NAICS code | 541714: Research and Development in Biotechnology (except Nanobiotechnology) |
Certifications and business types
- Women-owned (self-reported in SAM.gov)
- Women-owned small business (self-reported in SAM.gov)
SAM.gov's public file from Oct 5, 2026 lists no SBA certification (8(a), HUBZone or WOSB) for Synthis Therapeutics, Inc.. The file sometimes leaves a certification out, and a newer one won't be in it yet: SBA's certification search and the firm's SAM.gov entry have the current list. SBA certifications let a business compete for set-aside contracts. See set-aside contracts explained.
SBIR and STTR awards
Synthis Therapeutics, Inc. has won 4 small business R&D awards worth $3.1 million through the SBIR and STTR programs since 2018, 1 of them Phase II. Funded by NIH.
| Awarded | Agency | Project | Amount |
|---|---|---|---|
| Sep 18, 2024 | NIH | SBIR Phase II In vivo efficacy, safety and PK/PD analysis of SYN101, a first in class, immune cell targeted… | $2 million |
| Jun 1, 2023 | NIH | SBIR Phase I Development of a targeted TGF-b therapeutic that selectively blocks lung fibrosis in idiopathic… | $299,900 |
| Aug 1, 2019 | NIH | SBIR Phase I Development of a novel checkpoint inhibitor-TGF beta combination therapy to reverse immune… | $509,975 |
| Sep 14, 2018 | NIH | SBIR Phase I Development of a T cell-targeted TGF-b antagonist that reverses immune suppression in melanoma… | $299,946 |
Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.
Federal contract history
USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.
NAICS codes Synthis Therapeutics, Inc. is small under
On its SAM.gov registration, Synthis Therapeutics, Inc. meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Open contracts in Synthis Therapeutics, Inc.'s NAICS codes
27 open federal opportunities on SAM.gov use one of Synthis Therapeutics, Inc.'s NAICS codes and are open to it: no set-aside, or, in the code it is registered small under, a small business set-aside or one for a certification it holds. Here are a few, those in its primary code first (none of these are in New York right now), then the soonest due.
- UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Event or sign-up Oct 14, 2026
- Protein ENGineering (PENG)
✦ DARPA's Defense Sciences Office wants teams to build a platform that can edit existing (endogenous) proteins inside living cells, without permanently changing DNA. It is a…
Due in 8 daysOct 19, 2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
✦ NIH (NIDA) is running a sources sought notice, not a solicitation, to find companies that can run, consolidate or recompete NIH biorepositories for FY 2028.
Due in 9 daysOct 20, 2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
✦ NIH (through NIDA) is asking small businesses whether they can run one or more NIH biorepositories (sample banks) for FY 2028, including the NIDA Center for Genetic Studies and…
Due in 9 daysOct 20, 2026
- NAWCWD Broad Agency Announcement
Due in 19 daysOct 30, 2026
Similar small businesses
Other small businesses of a similar size with the same primary NAICS code (541714) that have won federal contracts in New York:
- Glyphic Biotechnologies, Inc., New York, NY
- Ifyber, LLC, Ithaca, NY
- Stellar Notch, LLC, New York, NY
- Ampersand Biosciences LLC, Lake Clear, NY
- Epibone, Inc., New York, NY
- Jan Biotech, Inc., Ithaca, NY
Frequently asked questions
What is Synthis Therapeutics, Inc.'s CAGE code?
Synthis Therapeutics, Inc.'s CAGE code is 7NWT8. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.
What is Synthis Therapeutics, Inc.'s UEI?
Synthis Therapeutics, Inc.'s Unique Entity ID (UEI) is KC6RHFHRQAN6. SAM.gov assigns the UEI, and it identifies the business across the federal government.
Is Synthis Therapeutics, Inc.'s SAM.gov registration active?
Yes, as of SAM.gov's public data from Oct 5, 2026, Synthis Therapeutics, Inc.'s registration is active through Jan 27, 2027. Registrations are renewed every year.
Is Synthis Therapeutics, Inc. a small business?
Synthis Therapeutics, Inc. is registered on SAM.gov as small under 1 NAICS code, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.
Keep going
- Look up another business's CAGE code or UEI
- Check a SAM.gov registration's status
- How to become a government subcontractor
Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To report a mistake on this page, or to ask us to remove it, email hello@fedready.us with the page address; we reply within 2 business days. For a removal, write from an address at the company.